Valuing the Global Mortality Consequences of Climate Change Accounting for Adaptation Costs and Benefits* Tamma Carleton , Amir Jina , Michael Delgado , Michael Greenstone , Trevor Houser , Solomon Hsiang , Andrew Hultgren , Robert E Kopp , Kelly E McCusker , Ishan Nath ...

https://blogs.worldbank.org/es/voices/calor-contaminacin-del-aire-y-perturbaciones-de-la-temperatura-mundial?cid=ECR_E_NewsletterWeekly_ES_EXT&deliveryName=DM293405 Abstract Using 40 countries’ subnational data, we estimate age-specific mortality-temperature relationships and extrapolate them to countries without data today and into a future with climate change. We uncover a U-shaped relationship where extre6me cold and hot temperatures increase mortality rates, especially for the elderly. Critically, this relationship is flattened by higher incomes and adaptation to local climate. Using a revealed-preference approach to recover unobserved adaptation costs, we estimate that the mean global increase in mortality risk due to climate change, accounting for adaptation benefits and costs, is valued at roughly 3.2% of global GDP in 2100 under a high-emissions scenario. Notably, today’s cold locations are projected to benefit, while today’s poor and hot locations have large projected damages. Finally, our central estimates indicate that the release of an additional ton of CO2 today will cause mortality-related damages of $36.6 under a high-emissions scenario, with an interquartile range accounting for both econometric and climate uncertainty of [−$7.8, $73.0]. These empirically grounded estimates exceed the previous literature’s estimates by an order of magnitude.

Rules Governing Human Oversight of AI in Health Care Could Shape Public Trust Joel Luther , Hagere Yilma , and Irving Washington

https://www.kff.org/health-information-trust/rules-governing-human-oversight-of-ai-in-health-care-could-shape-public-trust/ New regulations and guidelines for the use of AI in health care have sought to answer questions about human oversight and accountability. Separately, a new HHS initiative aims to expand research into potential vaccine injuries, but some medical organizations have questioned how the efforts may be perceived.

Viewpoints: The Stakes Are Huge For Democrats And Abortion Rights; Would You Want To Know If You Might Get Alzheimer's?

https://kffhealthnews.org/morning-breakout/viewpoints-pre-symptomatic-alzheimers-test-may-warn-of-future-risk-pros-and-cons-of-ai-potential-mind-reading/

Longer Looks: Interesting Reads You Might Have Missed

https://kffhealthnews.org/morning-breakout/longer-looks-interesting-reads-you-might-have-missed-282/

DC Shooting Suspect Was A Doctor With A Beef Against Condo's HOA, Metro Police Say

DC Shooting Suspect Was A Doctor With A Beef Against Condo's HOA, Metro Police Say Dr. Matt Lambert died of a self-inflicted gunshot wound during the rampage that left a Logan Circle building manager dead and others wounded, interim Metropolitan Police chief Jeffrey Carroll said. Other state news is about HIV prevention in Texas, a fear of cuts to disability services in Connecticut, and more. https://kffhealthnews.org/morning-breakout/state-watch-111326/

CMS Extends Medicare Enrollment Moratorium For 6 More Months On Hospice, Home Health Agencies

CMS Extends Medicare Enrollment Moratorium For 6 More Months On Hospice, Home Health Agencies According to the Centers for Medicare & Medicaid Services, the initial moratorium window has allowed the agency to identify potential cases of fraud and the extension is necessary to continue that effort. https://kffhealthnews.org/morning-breakout/health-industry-111326/

Allergy Drug Appears To Reduce Alpha-Gal Reactions To Red Meat, Study Shows

Allergy Drug Appears To Reduce Alpha-Gal Reactions To Red Meat, Study Shows In a limited study of the allergy drug omalizumab, 95% of participants experienced meaningful reductions in the frequency or severity of their allergic reactions, NBC News reported. Plus, an experimental heart drug fails its trial; Biogen's lupus study; and more. https://kffhealthnews.org/morning-breakout/pharma-and-tech-111326/